[Coronary artery bypass grafting surgery in left ventricular dysfunction patients complicated with mitral

Z X Wang1, X M Zhuang1, R Zhang1

  • 1Department of Cardiac Surgery, Fuwai Hospital Chinese Academy of Medical Sciences Shenzhen, Shenzhen 518057, China.

Insights

Coronary artery bypass grafting (CABG) surgery effectively treats left ventricular dysfunction with ischemic mitral regurgitation (IMR). Transesophageal echocardiography (TEE) guides treatment, with valve replacement improving cardiac function in severe cases.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Imaging
  • Heart Valve Disease

Background:

  • Left ventricular dysfunction (LVD) often coexists with ischemic mitral regurgitation (IMR).
  • The optimal surgical strategy for IMR in LVD patients remains a focus of research.
  • Accurate valve assessment is critical for successful surgical outcomes.

Purpose of the Study:

  • To assess the effectiveness of coronary artery bypass grafting (CABG) in patients with left ventricular dysfunction and varying degrees of ischemic mitral regurgitation (IMR).
  • To determine the role of transesophageal echocardiography (TEE) in guiding surgical decisions for IMR.
  • To evaluate the impact of different surgical interventions on postoperative cardiac function.

Main Methods:

  • Retrospective analysis of 525 patients undergoing CABG between 2015 and 2018.
  • Selection of 67 patients with moderate to severe IMR and left ventricular ejection fraction (LVEF) ≤40%.
  • Utilized transesophageal echocardiography (TEE) for detailed assessment of mitral valve function and cardiac structures.

Main Results:

  • In patients with moderate IMR and intact papillary muscles, CABG alone improved ventricular function without mitral valve intervention.
  • For moderate-to-severe IMR with improved wall motion post-CABG, mitral valve treatment was not required.
  • Severe IMR cases with papillary muscle or ring compromise benefited from valve repair (2 patients) or replacement (7 patients), leading to improved LVEF and reduced ventricular dimensions post-surgery.

Conclusions:

  • Transesophageal echocardiography (TEE) is essential for evaluating valve function in patients with LVD and IMR.
  • For moderate-to-severe IMR, valve replacement is recommended when ischemia significantly affects papillary muscle function and the mitral valve ring.
  • Surgical intervention tailored to the degree of IMR and valve structure integrity improves postoperative cardiac function.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
194
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
281
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
261
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
171
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
242
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
231